title: Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
authors.affiliation: Department of Urology, Yamagata University School of Medicine, Yamagata, Japan.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kato
authors.forename: Vladimir
authors.initials: V
authors.lastname: Bilim
authors.forename: Kaori
authors.initials: K
authors.lastname: Yuuki
authors.forename: Sei
authors.initials: S
authors.lastname: Naito
authors.forename: Takuya
authors.initials: T
authors.lastname: Yamanobe
authors.forename: Akira
authors.initials: A
authors.lastname: Nagaoka
authors.forename: Ikuya
authors.initials: I
authors.lastname: Yano
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Akaza
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Tomita
mesh_terms: D001500:BCG Vaccine / Q000494:pharmacology*; D048708:Cell Growth Processes / Q000276:immunology; D045744:Cell Line, Tumor; D017358:Cell Wall Skeleton / Q000276:immunology / Q000494:pharmacology; D051417:Focal Adhesion Kinase 1 / Q000096:biosynthesis / Q000276:immunology; D016193:G1 Phase / Q000276:immunology; D006801:Humans; D039081:Integrin alpha5beta1 / Q000096:biosynthesis / Q000276:immunology; D009163:Mycobacterium bovis / Q000276:immunology*; D015398:Signal Transduction; D051195:Toll-Like Receptor 2 / Q000096:biosynthesis / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000096:biosynthesis / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
chemical_list: D001500:BCG Vaccine; D017358:Cell Wall Skeleton; D039081:Integrin alpha5beta1; C495342:TLR2 protein, human; C495345:TLR4 protein, human; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human